Investor Notes - Phillip Securities (HK) Ltd
Past Investor Notes *Advertisement*
Phillip Home Send to Friends Free Subscription Give Comments 中文版
29 Oct, 2015 (Thursday)

            
PURAPHARM(1498)
Analysis:
PuraPharm (1498) is engaged in the research and development, production and sale of CCMG products under its brand “Nong's”. It is the largest supplier of CCMG products in Hong Kong and the sole supplier of CCMG products to the Hong Kong Hospital Authority. It is also one of only five CCMG product manufacturers and the only non-PRC company licensed by the CFDA to manufacture and sell CCMG products in China. It has entered into a distribution framework agreement with Sinopharm International, a Hong Kong subsidiary of Sinopharm Group (1099), which is one of the largest distributors of pharmaceutical and healthcare products in China, whereby Sinopharm International agreed to distribute its CCMG products in China. (I do not hold the above stock)
Strategy:
Buy-in Price: $4.55, Target Price: $5.10, Cut Loss Price: $4.35

WISDOM SPORTS(1661)
Analysis:
The physical fitness training is being included as the strategy of the state by the Chinese authority. It has been planned to expand the output scale of sport industry up to 5 trillion by 2025, given that the figure in 2015 is only 700 billion. This indicates that the CAGR for the upcoming 10 years would reach as high as 21.7%. Wisdom Holdings, being the top organizer of sport events and competitions, is expected to be consistently benefitted from such development. The Group has been renamed as “Wisdom Sports Group”, further indicated that the Company adopted the strategy of achieving a “sport specialist”. The Company's business on holding sport events and competitions is keeping speedy growth and enjoying strong profitability. The enormous sport events and competitions gave the chance for Wisdom Group to build up core competitiveness and support the mid-to-long term growth of the Group. Currently, the weight of revenue from the segment of Wisdom Events has significantly increased from the previous level of around 10%, to more than 30%, with contribution to profit reaching 40%. Moreover, the segment is with 60% of the gross profit margin, which is higher than the segment of Wisdom Program & Branding. Looking forward, Wisdom Events would achieve an annualized growth of more than 50%, with contribution to revenue moving up to higher than 50%.
Strategy:
Buy-in Price: $3.97, Target Price: $5.00, Cut Loss Price: $3.60


Galaxy Entertainment (27.HK) - Q3 results slightly better than expected

Q3 results slightly better than expected

Galaxy Entertainment recorded revenue of HKD12.3 billion, down 29% yoy, but up 5% QoQ. The Company's adjusted EBITDA amounted to HKD2.1 billion, down 36% yoy, but up 13% QoQ, including played unlucky which reduced EBITDA by approximately HKD130 million.

In Q3, the occupancy rate of the Company's hotels maintained as high as 99%. Two main brands of the Company had diversified performance. Galaxy Macau performed better in the period under review: recorded revenue of HKD8.7 billion, down 22% yoy, but up 9% QoQ; adjusted EBITDA amounted to HKD1.7 billion, down 30% yoy, but up 19% QoQ. It is worth to point out that Galaxy Macau recorded non-gaming revenue of HKD742 million, up 92% yoy and up 60% QoQ.

Star World Hotel recorded revenue of HKD2.9 billion, down 48% yoy and down 7% QoQ; adjusted EBITDA amounted to HKD514 million, down 43% yoy, but up 1% QoQ.

Overall, Galaxy Entertainment had good performance in Q3 and growth was recorded compared to Q2. The rate of decline of income and profit for the whole year narrowed and it reflected that the consistent downturn of VIP venue business was partially compensated by the growth of mass venue business. Moreover, demand for vocations and the launch of new projects also made Galaxy Entertainment more attractive to investors.

New change on operation performance

Fast growth of non-VIP gaming (mass gaming, slots and non-gaming), reduction on cost and launch of new projects were the positive changes on the Company's operation performance. Even though the gaming business of Macau has not yet moved away from depression, the above changes enhanced the Company's sustainable growth and gain on market share.

The market focus of Galaxy Entertainment is turning non-VIP gaming: the contribution of income from mass gaming, slots and non-gaming increased from one-third in 2014Q3 to the current approximately 50%; and such income contributed to the main part of EBITDA. Income from mass gaming, slots and non-gaming is expected to increase in amount as well as in weighting of EBITDA.

The development of Galaxy Macau Phase 2 and Broadway Macau in 2015Q2 provided the Company with new growth momentum. Broadway Macau recorded revenue of HKD189 million in Q3, and adjusted EBITDA of HKD-1 million (loss). A breakeven was basically recorded in the first financial quarter under operation. Moreover, effort made on cost reduction enabled a saving of more than HKD100 million in 2015Q3, and is expected to save HKD800 million in the upcoming 18 months.

Balance sheet kept solid

As at the end of September 2015, Galaxy Entertainment owns cash amounted to HKD6 billion, with net cash of HKD4.8 billion. Significant decrease of total debt was caused by the clearing of debts related to treasury management. Major items of capital expenditure in the coming 1 year include the site investigation works of Cotai Phases 3 & 4; and also the strategic investment of overseas markets. However, the amount of expenditure is expected to be limited.

Risk

The regulatory policies on the gaming business of Macau by the Central Chinese Government;

Weaken demand for VIP gaming;

Stronger competitors in Macau and nearby areas;

Labour cost and inflation in Macau.

Valuation

Q3 business data of Galaxy Entertainment is slightly better than expected, reflecting the positive changes of the fundamentals of the Company and also the steady recovery of demand. The Macau government has released some positive signals regarding gradual relaxation of regulations on gaming business in Macau and stimulation to tourism of Macau. We think these signals would generate positive boosting effects on the gaming business of Macau and particularly on Galaxy Entertainment. We give a rating of “Buy”, with the 12-month target price of HKD35, which is equivalent to 15.6x of 2016e EV/EBITDA and 22x of 2016e P/E. (Closing price as at 27 Oct 2015)

Financial Sheet

Click Here for PDF format...




Recommendation on 29-10-2015
RecommendationBuy
Price on Recommendation Date$ 26.800
Suggested purchase priceN/A
Target Price$ 35.000
Writer Info
Chen Geng
(Research Analyst)
Tel: +8621 51699400-107
Email:
chengeng@phillip.com.cn

Local Index
       Index    Change   Change%

World Index
       Index    Change   Change%
  

A-H spread
Stock Code H share
Price
A share
Price
H share
discount


Oversea Research Reports


Investment Service Centre


Stock Borrowing & Lending



Enquiry : 2277 6666 OR investornotes@phillip.com.hk
If you cannot read this e-mail in the proper format, please click here to view the web version.

Phillip Research - Hong Kong 輝立研究部 – 香港及中國
Company Stock Code Last Update Suggestion Target Price Price on Recom
Mainland Financial Xingyu Chen (86) 2151698900-105chenxingyu@phillip.com.cn
Ping An Insurance (Group) Company of China60131827/10/2015Buy6533.73
Agriculture Bank of China128809/10/2015Buy 43.09
Transportation and Automobiles Zhang Jing (86) 2151699200-103zhangjing@phillip.com.cn
Dongfeng48928/10/2015Accumulate12.5911.2
CAERI60196520/10/2015BUY11.49.12
Mainland Property Geng Chen (86) 2151699400-107chengeng@phillip.com.cn
Country Garden200722/10/2015Accumulate3.53.04
China State Construction International331114/10/2015Buy 15.811.48
Insurance Xingyu Chen (86) 2151699400-105chenxingyu@phillip.com.cn
Properties  
LESSO212823/09/2015Buy7.96.02
FORTUNE REIT77814/10/2014Accumulate7.326.92
Local Financials Xingyu Chen (86) 2151698900-105chenxingyu@phillip.com.cn
HSBC509/08/2013Accumulate100.484.25
HSBC Holdings PLC000509/05/2013Accumulate9587.7
Health & Personal Care Fan Guohe  (+ 86 21 51699400-110)fanguohe@phillip.com.cn
Yibai Pharmaceutical60059429/09/2015Buy21.5515.9
Tasly Pharmaceutical Group60053525/08/2015Buy 53.0838.73
Hotels and Entertainment Geng Chen (86) 2151699400-107chengeng@phillip.com.cn
Galaxy Entertainment2729/10/2015Buy35.000.000
Wisdom Group166105/01/2015BUY6.554.6
New Energy  
Dynagreen Env133026/10/2015BUY5.444.51
Kangda Env613619/10/2015BUY 4.052.63
Food, Beverage and Retail  
China Tianyi Holdings75616/10/2015Buy 20.97
Inner Mongolia Yili Industrial Group60088721/07/2015BUY26.418.99
Telecommunications  
Tongda Group69823/10/2015Buy1.91.58
NetDragon Websoft77715/10/2015Buy26.0420.85
Oil and Gas Geng Chen (86) 2151699400-107chengeng@phillip.com.cn
TSC GROUP20628/07/2015Buy2.82.11
SPT Energy125124/02/2015Reduce1.51.74
Software & Service  
Goldpac Group331518/02/2015N/A4.77
KINGDEE INT`L26802/12/2014Accumulate2.752.45

Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the “Group”) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products’ risks, please view the Risk Disclosures Statement on http://www.phillip.com.hk.

If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.

版權所有, 翻印必究。

Copyright(C) 2015 Phillip Securities (HK) Ltd. All Rights Reserved.